These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6104886)

  • 1. Low somatostatin content in cerebrospinal fluid in multiple sclerosis. An indicator of disease activity?
    Sørensen KV; Christensen SE; Dupont E; Hansen AP; Pedersen E; Orskov H
    Acta Neurol Scand; 1980 Mar; 61(3):186-91. PubMed ID: 6104886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis.
    Vécsei L; Csala B; Widerlöv E; Ekman R; Czopf J; Pàlffy G
    Brain Res Bull; 1990 Sep; 25(3):411-3. PubMed ID: 1981332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF somatostatin in multiple sclerosis: reversible loss of diurnal oscillation in relapses.
    Søorensen KV; Alslev T; Christensen SE; Jensen NB; Orskov H
    Neurology; 1987 Jun; 37(6):1050-3. PubMed ID: 2884594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin in multiple sclerosis.
    Sørensen KV
    Acta Neurol Scand; 1987 Mar; 75(3):161-7. PubMed ID: 2883805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
    Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
    Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis.
    Roca CA; Su TP; Elpern S; McFarland H; Rubinow DR
    Biol Psychiatry; 1999 Aug; 46(4):551-6. PubMed ID: 10459406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The origin of cerebrospinal fluid somatostatin: hypothalamic or disperse central nervous system secretion?
    Sørensen KV; Christensen SE; Hansen AP; Ingerslev J; Pedersen E; Orskov H
    Neuroendocrinology; 1981 Jun; 32(6):335-8. PubMed ID: 6165919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality.
    Dupont E; Christensen SE; Hansen AP; de Fine Olivarius B; Orskov H
    Neurology; 1982 Mar; 32(3):312-4. PubMed ID: 6121303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cerebrospinal fluid somatostatin in neurologic disease.
    Beal MF; Mazurek MF; Black PM; Martin JB
    J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF somatostatin increase in patients with early parkinsonian syndrome.
    Espino A; Calopa M; Ambrosio S; Ortolà J; Peres J; Navarro MA
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):189-96. PubMed ID: 8527003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapse.
    Bolton C; Turner AM; Turk JL
    J Neuroimmunol; 1984 Jun; 6(3):151-9. PubMed ID: 6586729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin concentrations in cerebrospinal fluid and brain tissue of patients with refractory epilepsy.
    Lang S; Peigen K; Liu J; Zhang F; Chen X; Liu Z
    Mol Chem Neuropathol; 1992 Dec; 17(3):239-47. PubMed ID: 1362876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF and plasma somatostatin levels in acromegaly.
    Wass JA; Penman E; Medbak S; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):235-41. PubMed ID: 6111404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CSF levels of somatostatin in patients with brain tumours and intracranial hypertension.
    Stepień H; Stawowy A; Cieślak D; Brzeziński J; Pawlikowski M
    Horm Metab Res; 1986 Aug; 18(8):555-7. PubMed ID: 2875924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.
    Scalabrino G; Galimberti D; Mutti E; Scalabrini D; Veber D; De Riz M; Bamonti F; Capello E; Mancardi GL; Scarpini E
    Brain Res; 2010 May; 1333():64-71. PubMed ID: 20347721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases.
    Page N; Perruisseau G; Steck AJ
    J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid somatostatin levels in febrile seizures and epilepsy in children.
    Hirai K; Seki T
    Neuropeptides; 2000 Feb; 34(1):18-24. PubMed ID: 10688964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.